Better Buy: AbbVie vs. Johnson & Johnson

One company produces the top-selling pharmaceuticals in the world. The other is a household name that offers various consumer health products as well as pharmaceutical products. Both are dealing with some hurdles and challenges.

We're talking about AbbVie (NYSE: ABBV) and Johnson & Johnson (NYSE: JNJ). Are either of these stocks worth buying right now? If so, which is the better buy? Let's take a closer look at each of these healthcare companies.

Image source: Getty Images.

Continue reading

Source Fool.com